Abstract
Objective: Human leukocyte antigen G (HLA-G) is a nonclassical class I molecule with immunosuppressive properties that may facilitate tumor immune escape. Elevated circulating soluble HLA-G (sHLA-G) levels have been reported in several malignancies. This study aimed to evaluate the diagnostic performance of serum sHLA-G levels in patients with lung cancer and to investigate whether smoking status influences these levels.Materials and Methods: This case–control study included 62 patients with newly diagnosed lung cancer, 40 smoker controls, and 31 nonsmoker healthy controls. Serum sHLA-G levels were measured using an enzyme-linked immunosorbent assay (ELISA). Statistical comparisons among groups were performed using one-way analysis of variance and correlation analyses. Receiver operating characteristic (ROC) curve analysis was conducted to assess the diagnostic performance of sHLA-G.Results: Mean serum sHLA-G levels were significantly higher in patients with lung cancer than in nonsmoker controls (16.14 ± 8.71 U/mL vs 10.21 ± 4.77 U/mL, p=0.04). When smoker and nonsmoker controls were combined, the difference remained significant (p
Funding Information
  • Düzce University (2012.04.HD.040)

This publication has 17 references indexed in Scilit: